Combining genome-wide polygenic scores with registry data for colorectal cancer risk-based screening
People with genetic risk factors develop colon cancer roughly a decade earlier than average, suggesting genetic screening could enable earlier and more personalized cancer prevention strategies.
In 112,204 individuals with linked genomic and registry data (Copenhagen Hospital Biobank), CRC polygenic risk scores robustly stratified lifetime adenoma and cancer risk independently of ancestry, sex, and tumor location. The key clinical insight is that high-PRS individuals reach average-risk CRC incidence a decade earlier than low-PRS peers, supporting earlier screening initiation for genetically identified high-risk groups rather than point-in-time FIT augmentation.
What the study was
- Study design
- large_population_registry_cohort
- Category
- sentinel
- Maturity
- Validated
- Journal
- British Journal of Cancer
Why it surfaced
Large-scale population genomics study with direct CRC screening policy implications; age-shifted screening timing for high-PRS individuals has practical uptake potential in precision prevention programs. Score 8 (N=2, D=2, P=2, E=2) reflects solid registry-linked design and immediate guideline-informing evidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.